Claire Ellen Launches New Analgesic Neuroquell
Neuroquell works by inhibiting or stopping the nerve pain impulse signals as they travel from one nerve cell to another, (called a synapse). Claire Ellen Products claimed that

Neuroquell works by inhibiting or stopping the nerve pain impulse signals as they travel from one nerve cell to another, (called a synapse). Claire Ellen Products claimed that

The technology allows a single in-office minimally invasive surgical procedure. The patent also allows the device to deliver medication or therapeutic agents to the uterine cavity. ContraMed has

Pharmadule’s scope comprises design, fabrication, installation and validation of a complete biotech production facility. Pharmadule said that its modular concept allows 80% of the construction to be completed

With the availability of OVA1, physicians can assess, prior to a planned surgery, the likelihood that a woman’s ovarian mass is malignant in order to direct her to

Varian is a supplier of scientific instruments and vacuum technologies for life science, environmental, energy and applied research and other applications. The company provides complete solutions, including instruments,

The grant has been designed to shrink technology found in large hospital hematology analyzers, typically the size of small refrigerators, to a tiny, palm-sized device. The emergency blood

The team said that their work could help to reduce the possibility and risk of infections amongst newborn babies, along with the development of new and suitable treatments.

Additionally, Odyssey Thera has granted to Lonza an option to certain exclusive global technology licenses. The companies have also initiated collaborative technology, product development and marketing activities. Under

With over 500 employees in the US, the European Union and Canada, requiring IT support, Axcan Pharma decided to evaluate the activities/services of its outsourced IT support provider.

Brian Scanlan, chief business officer of Cambridge Major Laboratories, said: “Chemistry Playbook accelerates drug development from carbon to commercialization by delivering where other competitive, expedited programs fall short: